DATATRAK International, Inc. (DTRK)
OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.1499 (-16.66%)
At close: Oct 16, 2025
DATATRAK International Market Cap
DATATRAK International has a market cap or net worth of $23.59 million as of October 16, 2025. Its market cap has increased by 412.93% in one year.
Market Cap
23.59M
Enterprise Value
n/a
Revenue
6.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since June 11, 1996, DATATRAK International's market cap has increased from 5.94M to 23.59M, an increase of 297.34%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 23.59M | 844.59% |
| Dec 31, 2024 | 2.50M | 896.55% |
| Dec 29, 2023 | 250.60K | -77.06% |
| Dec 30, 2022 | 1.09M | -94.94% |
| Dec 30, 2021 | 21.57M | 52.52% |
| Dec 31, 2020 | 14.14M | -7.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |